Analyst Ratings for Cardiff Oncology (CRDF)

CRDF Rating Summary

CRDF Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRDF
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $6.67 (+511.6%) * Over Last 12-Mos
Rating Score: 5.8 / 10   Percentile Rank: 61%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/12/2026 William Blair Andy T. Hsieh Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 1.03
(1.09)		 5.83% Details
6/3/2026 Craig-Hallum Albert Lowe Downgrade Hold
(Buy)		 2.00
(N/A)		 1.51
(1.09)		 -27.81% Details